 |
인쇄하기
취소
|
CJ teams up with Japanese biopharmaceutical firm
CJ CheilJedang Corporation signed an agreement with RaQuaria Co. on July 7, a promising biopharmaceutical company in Japan for the development of new antiulcer drugs.
“The two companies would jointly invest a sizable money in theresearch and development (R&D) program to acquire technologies needed to produce future drugs for the treatment of indigestion,'' said, Sohn Suk-hee of CJ CheilJedan...
“The two companies would jointly invest a sizable money in theresearch and development (R&D) program to acquire technologies needed to produce future drugs for the treatment of indigestion,'' said, Sohn Suk-hee of CJ CheilJedan...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.